Cargando…
Tizoxanide Promotes Apoptosis in Glioblastoma by Inhibiting CDK1 Activity
The antiparasitic drug nitazoxanide (NTZ) has received considerable attention for its potential in cancer therapy. In this study, we demonstrate that tizoxanide (TIZ), an active metabolite of NTZ, exhibits antiglioma activity in vitro and in vivo by inducing G2/M cell cycle arrest and apoptosis. In...
Autores principales: | Huang, Si, Xiao, Jingxian, Wu, Junyong, Liu, Jiayi, Feng, Xueping, Yang, Chengdong, Xiang, Daxiong, Luo, Shilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174573/ https://www.ncbi.nlm.nih.gov/pubmed/35694267 http://dx.doi.org/10.3389/fphar.2022.895573 |
Ejemplares similares
-
Tizoxanide pyridine monosolvate
por: Zheng, Huaqin, et al.
Publicado: (2012) -
Tizoxanide as a novel theraputic candidate for osteoarthritis
por: Ni, Bowei, et al.
Publicado: (2023) -
Tizoxanide Antiviral Activity on Dengue Virus Replication
por: Yamamoto, Kristie A., et al.
Publicado: (2023) -
Quantitative proteomic analysis of the tizoxanide effect in vero cells
por: Yamamoto, K. A., et al.
Publicado: (2020) -
Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years
por: Hao, Xinyan, et al.
Publicado: (2022)